Document Actions

Journal articles

2016 






 
 

 

 

 

2015








   






 

 

 

 

 

 

 2014









 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 2013












2012
















 

 

 2011








 

 

 

 

 

 

 

 

 

 

2010















prior 2010

Wernicke AK, Churin Y, Sheridan D, Windhorst A, Tschuschner A, Gattenlohner S, Roderfeld M, Roeb E. Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions. Oncotarget (2016);in press.

 

Roeb E, Steffen HM, Bojunga J. [Non-alcoholic fatty liver disease--What's new]. Dtsch Med Wochenschr (2016);141:494-496.

 

Montalbano R, Honrath B, Wissniowski TT, Elxnat M, Roth S, Ocker M, Quint K, Churin Y, Roederfeld M, Schroeder D, Glebe D, Roeb E, Di FP. Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells. Oncotarget (2016);7:20312-20323.

 

Atta H, El-Rehany M, Roeb E, bdel-Ghany H, Ramzy M, Gaber S. Mutant matrix metalloproteinase-9 reduces postoperative peritoneal adhesions in rats. Int J Surg (2016);26:58-63.

 

Graumann F, Churin Y, Tschuschner A, Reifenberg K, Glebe D, Roderfeld M, Roeb E. Genomic Methylation Inhibits Expression of Hepatitis B Virus Envelope Protein in Transgenic Mice: A Non-Infectious Mouse Model to Study Silencing of HBV Surface Antigen Genes. PLoS One (2015);10:e0146099.

 

Roeb E, Steffen HM, Bojunga J. [Non-alcoholic fatty liver diseases]. Dtsch Med Wochenschr (2015);140:1846.

 

Roeb E, Steffen HM, Bantel H, Baumann U, Canbay A, Demir M, Drebber U, Geier A, Hampe J, Hellerbrand C, Pathil-Warth A, Schattenberg JM, Schramm C, Seitz HK, Stefan N, Tacke F, Tannapfel A, Lynen JP, Bojunga J. [S2k Guideline non-alcoholic fatty liver disease]. Z Gastroenterol (2015);53:668-723.

 

Weiss J, Rau M, Bantel H, Bock H, Demir M, Kluwe J, Krawczyk M, Pathil-Warth A, Schattenberg JM, Tacke F, Roeb E, Geier A. [First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology]. Z Gastroenterol (2015);53:562-567.

 

Churin Y, Roderfeld M, Stiefel J, Wurger T, Schroder D, Matono T, Mollenkopf HJ, Montalbano R, Pompaiah M, Reifenberg K, Zahner D, Ocker M, Gerlich W, Glebe D, Roeb E. Correction: pathological impact of hepatitis B virus surface proteins on the liver is associated with the host genetic background. PLoS One (2015);10:e0127375.

 

Churin Y, Roderfeld M, Roeb E. Hepatitis B virus large surface protein: function and fame. Hepatobiliary Surg Nutr (2015);4:1-10.

 

Kampschulte M, Erdmann G, Sender J, Martels G, Bocker W, ElKhassawna T, Heiss C, Langheinrich AC, Roeb E, Roderfeld M, Krombach GA. The development and validation of micro-CT of large deep frozen specimens. Scanning (2015);37:63-72.

 

Rath T, Zwaschka L, Hage L, Kugler M, Menendez K, Naehrlich L, Schulz R, Roderfeld M, Roeb E. Identification of neutrophil activation markers as novel surrogate markers of CF lung disease. PLoS One (2014);9:e115847.

 

Atta H, El-Rehany M, Hammam O, bdel-Ghany H, Ramzy M, Roderfeld M, Roeb E, Al-Hendy A, Raheim SA, Allam H, Marey H. Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One (2014);9:e112384.

 

Kampschulte M, Stockl C, Langheinrich AC, Althohn U, Bohle RM, Krombach GA, Stieger P, Churin Y, Kremer S, Dierkes C, Rath T, Roeb E, Roderfeld M. Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis. Lab Invest (2014);94:1273-1282.

 

Atreya R, Bulte M, Gerlach GF, Goethe R, Hornef MW, Kohler H, Meens J, Mobius P, Roeb E, Weiss S. Facts, myths and hypotheses on the zoonotic nature of Mycobacterium avium subspecies paratuberculosis. Int J Med Microbiol (2014);304:858-867.

 

Roeb E, Graf J, Meyer HJ. [Actors in liver transplantation advocate greater transparency and systematic evaluations of transplant centres]. Z Gastroenterol (2014);52:807-812.

 

Felber J, Aust D, Baas S, Bischoff S, Blaker H, Daum S, Keller R, Koletzko S, Laass M, Nothacker M, Roeb E, Schuppan D, Stallmach A. [Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity]. Z Gastroenterol (2014);52:711-743.

 

Koc A, Bargen I, Suwandi A, Roderfeld M, Tschuschner A, Rath T, Gerlach GF, Hornef M, Goethe R, Weiss S, Roeb E. Systemic and mucosal immune reactivity upon Mycobacterium avium ssp. paratuberculosis infection in mice. PLoS One (2014);9:e94624.

 

Churin Y, Roderfeld M, Stiefel J, Wurger T, Schroder D, Matono T, Mollenkopf HJ, Montalbano R, Pompaiah M, Reifenberg K, Zahner D, Ocker M, Gerlich W, Glebe D, Roeb E. Pathological impact of hepatitis B virus surface proteins on the liver is associated with the host genetic background. PLoS One (2014);9:e90608.

 

Roeb E. [NASH (non-alcoholic steatohepatitis): fatty liver or fatal liver disease?]. Zentralbl Chir (2014);139:168-174.


Roeb E. [Hepatocellular carcinoma - current aspects of screening, surveillance and therapeutic strategies (revised EASL-EORTC recommendations)]. Zentralbl Chir (2014);139:175-183.

 

Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geissler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Lohr M, Luttges J, Lutz M, Mayerle J, Michl P, Moller P, Molls M, Munter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Rocken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van OB, Vashist Y, Werner J, Yekebas E. [S3-guideline exocrine pancreatic cancer]. Z Gastroenterol (2013);51:1395-1440.

 

Rath T, Hage L, Kugler M, Menendez MK, Zachoval R, Naehrlich L, Schulz R, Roderfeld M, Roeb E. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. PLoS One (2013);8:e58955.

 

Roeb E, Dreyer T, Steiner D, Brauninger A, Gattenlohner S. [A 75-year-old female patient with pleural effusion and gastric metastases of a poorly differentiated carcinoma]. Internist (Berl) (2013);54:242, 244-242, 248.

 

Rath T, Menendez KM, Kugler M, Hage L, Wenzel C, Schulz R, Graf J, Nahrlich L, Roeb E, Roderfeld M. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease. Dig Liver Dis (2012);44:780-787.

 

Roeb E, Etschmann B, Gattenlohner S. Is it always Crohn's disease in a patient with perianal fistulae and skip lesions in the colon? Gastroenterology (2012);143:e7-e8.

 

Roderfeld M, Koc A, Rath T, Blocher S, Tschuschner A, Akineden O, Fischer M, von GS, Goethe R, Eckelt E, Meens J, Bulte M, Basler T, Roeb E. Induction of matrix metalloproteinases and TLR2 and 6 in murine colon after oral exposure to Mycobacterium avium subsp. paratuberculosis. Microbes Infect (2012);14:545-553.

 

Schmitt J, Roderfeld M, Sabrane K, Zhang P, Tian Y, Mertens JC, Frei P, Stieger B, Weber A, Mullhaupt B, Roeb E, Geier A. Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile duct-ligated mice. Biochem Biophys Res Commun (2012);418:445-450.


Roderfeld M, Rath T, Pasupuleti S, Zimmermann M, Neumann C, Churin Y, Dierkes C, Voswinckel R, Barth PJ, Zahner D, Graf J, Roeb E. Bone marrow transplantation improves hepatic fibrosis in Abcb4-/- mice via Th1 response and matrix metalloproteinase activity. Gut (2012);61:907-916.


Schmeiser T, Saar P, Jin D, Noethe M, Muller A, Soydan N, Hardt PD, Jaeger C, Distler O, Roeb E, Bretzel RG, Muller-Ladner U. Profile of gastrointestinal involvement in patients with systemic sclerosis. Rheumatol Int (2012);32:2471-2478.

 

Roeb E, Rummel M, Blau W, Etschmann B, Gattenlohner S. B-cell lymphoma in a tubular adenoma with high-grade dysplasia: a rare extramedullary manifestation of high-grade diffuse large B-cell lymphoma. Endoscopy (2011);43 Suppl 2 UCTN:E344-E345.

 

Rath T, Roderfeld M, Guler C, Wenzel C, Graf J, Beitinger F, Roeb E, Zachoval R. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis. Scand J Gastroenterol (2011);46:1369-1380.

 

Brauer R, Beck IM, Roderfeld M, Roeb E, Sedlacek R. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen. BMC Biochem (2011);12:38.

 

Dietrich CG, Vehr AK, Martin IV, Gassler N, Rath T, Roeb E, Schmitt J, Trautwein C, Geier A. Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen. Int J Cancer (2011);129:546-552.

 

Rath T, Stockle J, Roderfeld M, Tschuschner A, Graf J, Roeb E. Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration. Oncol Lett (2011);2:483-488.

 

Rath T, Roderfeld M, Blocher S, Rhode A, Basler T, Akineden O, Abdulmawjood A, Halwe JM, Goethe R, Bulte M, Roeb E. Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis. BMC Gastroenterol (2011);11:34.

 

Rath T, Roeb E, Doppl WE. Pneumatosis coli as a rare complication of bowel preparation. Endoscopy (2010);42 Suppl 2:E344-E345.

 

Roderfeld M, Rath T, Lammert F, Dierkes C, Graf J, Roeb E. Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC. World J Hepatol (2010);2:175-179.

 

Rath T, Roderfeld M, Halwe JM, Tschuschner A, Roeb E, Graf J. Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis. Scand J Gastroenterol (2010);45:1186-1196.

 

Javier Redondo-Munoz, Estefania Ugarte-Berzal, Maria Jose Terol, Philippe E. Van den Steen, Mercedes Hernandez del Cerro, Martin Roderfeld, Elke Roeb, Ghislain Opdenakker, Jose A. Garcia-Marco, and Angeles Garcia-Pardo. Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain. Cancer Cell (2010);17:160–172.

Roderfeld M, Rath T, Voswinckel R, Dierkes C, Dietrich H, Zahner D, Graf J, Roeb E. Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.  Hepatology (2010);51:267-276.

Graf J, Roeb E, Janssens U. Under pressure ... do not get lost in space.  Crit Care Med (2009);37:2986-2987.

Rath T, Roderfeld M, Graf J, Roeb E. [Matrix metalloproteinases in inflammatory bowel disease - from basic research to clinical significance].  Z Gastroenterol (2009);47:758-769.

Roderfeld M, Rath T, Schulz R, Seeger W, Tschuschner A, Graf J, Roeb E. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation.  J Cyst Fibros (2009);8:338-347.

Graf J, Roeb E. [Monitoring of basic functions in intensive care: benefits and risks].  Dtsch Med Wochenschr (2009);134:29-34.

Roderfeld M, Weiskirchen R, Atanasova S, Gressner AM, Preissner KT, Roeb E, Kanse SM. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells.  Liver Int (2009);29:686-691.

Salguero PR, Roderfeld M, Hemmann S, Rath T, Atanasova S, Tschuschner A, Gressner OA, Weiskirchen R, Graf J, Roeb E. Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice.  Lab Invest (2008);88:1192-1203.

Manetti M, Neumann E, Muller A, Schmeiser T, Saar P, Milia AF, Endlicher E, Roeb E, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L, Muller-Ladner U. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.  Arthritis Rheum (2008);58:2866-2873.

Graf J, Muhlhoff C, Doig GS, Reinartz S, Bode K, Dujardin R, Koch KC, Roeb E, Janssens U. Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest.  Crit Care (2008);12:R92.

Roderfeld M, Graf J, Giese B, Salguero-Palacios R, Tschuschner A, Muller-Newen G, Roeb E. Latent MMP-9 is bound to TIMP-1 before secretion.  Biol Chem (2007);388:1227-1234.

Doppl WE, Kuttner D, Stolte M, Breithecker A, Padberg W, Franke FE, Roeb E. Clinical challenges and images in GI. Segmental ischemic colitis owing to vascular malformation of the inferior mesenteric artery.  Gastroenterology (2007);133:15, 373.

Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.  J Hepatol (2007);46:955-975.

Burg-Roderfeld M, Roderfeld M, Wagner S, Henkel C, Grotzinger J, Roeb E. MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells.  Int J Oncol (2007);30:985-992.

Roderfeld M, Hemmann S, Roeb E. Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs).  Z Gastroenterol (2007);45:25-33.

Henkel C, Roderfeld M, Weiskirchen R, Berres ML, Hillebrandt S, Lammert F, Meyer HE, Stuhler K, Graf J, Roeb E. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis.  Proteomics (2006);6:6538-6548.

Rath T, Roderfeld M, Graf J, Wagner S, Vehr AK, Dietrich C, Geier A, Roeb E. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?.  Inflamm Bowel Dis (2006);12:1025-1035.

Roderfeld M, Geier A, Dietrich CG, Siewert E, Jansen B, Gartung C, Roeb E. Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up-regulates matrix metalloproteinase-9 in toxic liver injury.  Liver Int (2006);26:579-586.

Roderfeld M, Weiskirchen R, Wagner S, Berres ML, Henkel C, Grotzinger J, Gressner AM, Matern S, Roeb E. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice.  FASEB J (2006);20:444-454.

Yao C, Roderfeld M, Rath T, Roeb E, Bernhagen J, Steffens G. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices.  Biomaterials (2006);27:1608-1616.

Roeb E, Bosserhoff AK, Hamacher S, Jansen B, Dahmen J, Wagner S, Matern S. Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: relevance to intracellular signaling pathways.  World J Gastroenterol (2005);11:1096-1104.

Henkel C, Roderfeld M, Weiskirchen R, Scheibe B, Matern S, Roeb E. Identification of fibrosis-relevant proteins using DIGE (difference in gel electrophoresis) in different models of hepatic fibrosis.  Z Gastroenterol (2005);43:23-29.

Roeb E, Benders J, Matern S. Walled-off esophageal perforation as a first manifestation of pulmonary tuberculosis.  Gastrointest Endosc (2004);60:1026-1028.

Hamacher S, Matern S, Roeb E. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].  Dtsch Med Wochenschr (2004);129:1976-1980.

Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.  Int J Colorectal Dis (2004);19:518-524.

Dietrich CG, Geier A, Salein N, Lammert F, Roeb E, Oude Elferink RP, Matern S, Gartung C. Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2. Gastroenterology (2004);126:1044-1053.

Roeb E, Matern S. [Matrix metalloproteinases and colorectal cancer].  Med Klin (Munich) (2003);98:763-770.

Roderfeld M, Matern S, Roeb E. [Confocal laser scanning microscopy: a deep look into the cell].  Dtsch Med Wochenschr (2003);128:2539-2542.

Roeb E, Purucker E, Gartung C, Geier A, Jansen B, Winograd R, Matern S. Effect of glutathione depletion and hydrophilic bile acids on hepatic acute phase reaction in rats with extrahepatic cholestasis.  Scand J Gastroenterol (2003);38:878-885.

Roeb E, Schleinkofer K, Kernebeck T, Potsch S, Jansen B, Behrmann I, Matern S, Grotzinger J. The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.  J Biol Chem (2002);277:50326-50332.

Roeb E, Dietrich CG, Winograd R, Arndt M, Breuer B, Fass J, Schumpelick V, Matern S. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9.  Cancer (2001);92:2680-2691.

Roeb E, Matern S. [Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors].  Z Gastroenterol (2001);39:807-813.

Ellis E, Roeb E, Marschall H. Primary cultures of human hepatocytes but not HepG2 hepatoblastoma cells are suitable for the study of glycosidic conjugation of bile acids.  Biochim Biophys Acta (2001);1530:155-161.

Dietrich CG, Roeb E, Breuer E, Matern S. [Solitary fibrous thoracic wall tumor. Progression with percutaneous radiotherapy].  Dtsch Med Wochenschr (2001);126:12-15.

Roeb E, Behrmann I, Grotzinger J, Breuer B, Matern S. An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist.  FASEB J (2000);14:1671-1673.

Thier M, Roeb E, Breuer B, Bayer TA, Halfter H, Weis J. Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate.  Cancer Lett (2000);149:163-170.

Roeb E, Winograd R, Breuer B, Nguyen H, Matern S. Increased TIMP-1 activity results in increased expression of gelatinases and altered cell motility  J Cell Biochem (1999);75:346-355.

Bayer TA, Thier M, Roeb E, Breuer B, Weggen S, Wiestler OD, Weis J. Migratory potential of transplantable neural tumor cell lines  Acta Neuropathol (1999);97:607-612.

Purucker E, Winograd R, Roeb E, Matern S. Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation  Res Exp Med (Berl) (1998);198:167-174.

Nguyen HN, Silny J, Albers D, Roeb E, Gartung C, Rau G, Matern S. Dynamics of esophageal bolus transport in healthy subjects studied using multiple intraluminal impedancometry  Am J Physiol (1997);273:G958-G964.

Roeb E, Purucker E, Breuer B, Nguyen H, Heinrich PC, Rose-John S, Matern S. TIMP expression in toxic and cholestatic liver injury in rat  J Hepatol (1997);27:535-544.

Marschall HU, Roeb E, Yildiz Y, Busch N, Nguyen H, Purucker E, Thomas HG, Matern S. Study of human isoursodeoxycholic acid metabolism  J Hepatol (1997);26:863-870.

Roeb E, Rose-John S. [Cytokines: biology and therapeutic relevance]  Dtsch Med Wochenschr (1996);121:803-809.

Roeb E, Schonfelder T, Matern S, Sieberth HG, Lenz W, Lutticken R, Reinert RR. Staphylococcal scalded skin syndrome in an immunocompromised adult  Eur J Clin Microbiol Infect Dis (1996);15:499-503.

Kurschat P, Graeve L, Erren A, Gatsios P, Rose-John S, Roeb E, Tschesche H, Koj A, Heinrich PC. Expression of a biologically active murine tissue inhibitor of metalloproteinases-1 (TIMP-1) in baculovirus-infected insect cells. Purification and tissue distribution in the rat  Eur J Biochem (1995);234:485-491.

Peters M, Roeb E, Pennica D, Meyer zum Buschenfelde KH, Rose-John S. A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1)  FEBS Lett (1995);372:177-180.

Roeb E, Graeve L, Mullberg J, Matern S, Rose-John S. TIMP-1 protein expression is stimulated by IL-1 beta and IL-6 in primary rat hepatocytes  Ann N Y Acad Sci (1995);762:462-464.

Mackiewicz A, Wiznerowicz M, Roeb E, Nowak J, Pawlowski T, Baumann H, Heinrich PC, Rose-John S. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma  Ann N Y Acad Sci (1995);762:361-373.

Mackiewicz A, Wiznerowicz M, Roeb E, Karczewska A, Nowak J, Heinrich PC, Rose-John S. Soluble interleukin 6 receptor is biologically active in vivo  Cytokine (1995);7:142-149.

Roeb E, Rose-John S, Erren A, Edwards DR, Matern S, Graeve L, Heinrich PC. Tissue inhibitor of metalloproteinases-2 (TIMP-2) in rat liver cells is increased by lipopolysaccharide and prostaglandin E2  FEBS Lett (1995);357:33-36.

Horn F, Wegenka UM, Lutticken C, Yuan J, Roeb E, Boers W, Buschmann J, Heinrich PC. Regulation of alpha 2-macroglobulin gene expression by interleukin-6  Ann N Y Acad Sci (1994);737:308-323.

Roeb E, Graeve L, Mullberg J, Matern S, Rose-John S. TIMP-1 protein expression is stimulated by IL-1 beta and IL-6 in primary rat hepatocytes  FEBS Lett (1994);349:45-49.

Wegenka UM, Lutticken C, Buschmann J, Yuan J, Lottspeich F, Muller-Esterl W, Schindler C, Roeb E, Heinrich PC, Horn F. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family  Mol Cell Biol (1994);14:3186-3196.

Roeb E, Matern S. [Fibronectin--a key substance in pathogenesis of liver cirrhosis?]  Leber Magen Darm (1993);23:239-242.

Roeb E, Graeve L, Hoffmann R, Decker K, Edwards DR, Heinrich PC. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures  Hepatology (1993);18:1437-1442.

Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-John S. Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes  FEBS Lett (1992);314:280-284.

Kordula T, Guttgemann I, Rose-John S, Roeb E, Osthues A, Tschesche H, Koj A, Heinrich PC, Graeve L. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interleukin-6 and transforming growth factor beta 1  FEBS Lett (1992);313:143-147.

Kammermeier H, Roeb E, Jungling E, Meyer B. Regulation of systolic force and control of free energy of ATP-hydrolysis in hypoxic hearts  J Mol Cell Cardiol (1990);22:707-713.

Kammermeier H, Roeb E. Is force production in the hypoxic myocardium dependent on cytosolic inorganic phosphate?  Pflugers Arch (1987);410:671-673.